The randomized, double-blind, placebo-controlled anddose escalation I phase study evaluating the tolerence, pharmacokenetics and efficacy of single dose andescalating dose to target dose every week of CJC-1134- PC in healthy subjects

The randomized, double-blind, placebo-controlled anddose escalation I phase study evaluating the tolerence, pharmacokenetics and efficacy of single dose andescalating dose to target dose every week of CJC-1134- PC in healthy subjects